IDR 2370.0
(-2.47%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1207.01 Billion IDR | -11.67% |
2022 | 1340.9 Billion IDR | -19.62% |
2021 | 1668.2 Billion IDR | 49.74% |
2020 | 1114.05 Billion IDR | 18.19% |
2019 | 942.62 Billion IDR | 20.8% |
2018 | 780.32 Billion IDR | 2.71% |
2017 | 759.75 Billion IDR | 1.88% |
2016 | 745.71 Billion IDR | 23.28% |
2015 | 604.92 Billion IDR | 3.17% |
2014 | 586.32 Billion IDR | 21.68% |
2013 | 481.83 Billion IDR | 28.74% |
2012 | 374.28 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 344.54 Billion IDR | -9.37% |
2024 Q1 | 375.02 Billion IDR | 53.25% |
2024 Q2 | 380.15 Billion IDR | 1.37% |
2023 Q2 | 285.96 Billion IDR | -2.97% |
2023 Q4 | 244.71 Billion IDR | -25.14% |
2023 Q3 | 326.88 Billion IDR | 14.31% |
2023 FY | 1184.46 Billion IDR | -11.67% |
2023 Q1 | 294.7 Billion IDR | -11.0% |
2022 FY | 1340.9 Billion IDR | -19.62% |
2022 Q3 | 299.65 Billion IDR | -12.43% |
2022 Q4 | 331.11 Billion IDR | 10.5% |
2022 Q2 | 342.2 Billion IDR | -6.99% |
2022 Q1 | 367.92 Billion IDR | -7.72% |
2021 Q4 | 398.72 Billion IDR | 6.63% |
2021 FY | 1668.2 Billion IDR | 49.74% |
2021 Q3 | 373.91 Billion IDR | -12.51% |
2021 Q2 | 427.4 Billion IDR | -8.71% |
2021 Q1 | 468.16 Billion IDR | 6.36% |
2020 FY | 1114.05 Billion IDR | 18.19% |
2020 Q4 | 440.18 Billion IDR | 41.74% |
2020 Q1 | 265.18 Billion IDR | 10.68% |
2020 Q2 | 98.12 Billion IDR | -63.0% |
2020 Q3 | 310.55 Billion IDR | 216.47% |
2019 Q4 | 239.59 Billion IDR | 8.98% |
2019 FY | 942.62 Billion IDR | 20.8% |
2019 Q3 | 219.85 Billion IDR | -6.81% |
2019 Q2 | 235.91 Billion IDR | -4.58% |
2019 Q1 | 247.25 Billion IDR | 40.84% |
2018 Q2 | 195.42 Billion IDR | -4.73% |
2018 Q1 | 205.13 Billion IDR | 17.23% |
2018 FY | 780.32 Billion IDR | 2.71% |
2018 Q4 | 175.55 Billion IDR | -14.04% |
2018 Q3 | 204.21 Billion IDR | 4.5% |
2017 Q1 | 201.16 Billion IDR | 14.51% |
2017 Q2 | 190.76 Billion IDR | -5.17% |
2017 FY | 759.75 Billion IDR | 1.88% |
2017 Q4 | 174.98 Billion IDR | -9.26% |
2017 Q3 | 192.83 Billion IDR | 1.08% |
2016 Q1 | 198.99 Billion IDR | 56.42% |
2016 FY | 745.71 Billion IDR | 23.28% |
2016 Q4 | 175.67 Billion IDR | 5.55% |
2016 Q3 | 166.44 Billion IDR | -18.65% |
2016 Q2 | 204.6 Billion IDR | 2.82% |
2015 Q3 | 134.61 Billion IDR | -22.07% |
2015 Q4 | 127.22 Billion IDR | -5.49% |
2015 FY | 604.92 Billion IDR | 3.17% |
2015 Q1 | 170.34 Billion IDR | 16.41% |
2015 Q2 | 172.74 Billion IDR | 1.41% |
2014 Q2 | 166 Billion IDR | 7.89% |
2014 Q4 | 146.33 Billion IDR | 21.82% |
2014 FY | 586.32 Billion IDR | 21.68% |
2014 Q3 | 120.11 Billion IDR | -27.64% |
2014 Q1 | 153.86 Billion IDR | 0.0% |
2013 FY | 481.83 Billion IDR | 28.74% |
2012 FY | 374.28 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Bundamedik Tbk | 211.43 Billion IDR | -470.861% |
PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 3439.955% |
PT Medikaloka Hermina Tbk | 780.69 Billion IDR | -54.607% |
PT Murni Sadar Tbk | 15.2 Billion IDR | -7837.765% |
PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | -490.463% |
PT Royal Prima Tbk | -4.62 Billion IDR | 26214.357% |
PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | -3991.953% |
PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | -2450.39% |
PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 30.161% |
PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | -1035.9% |